Congress Materials

Medical Information
Ireland
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a healthcare professionalYes, I am a healthcare professional
SelectI am a healthcare professionalYes, I am a healthcare professional
I am a Patient/Caregiver or
Member of the General PublicNo, go back to the patient portal
SelectI am a Patient/Caregiver or
Member of the General PublicNo, go back to the patient portal

If you don't reside in Ireland, please click here

The medical information on this site is intended only for healthcare professionals in the Republic of Ireland. The products discussed herein may have different product labeling in other countries.

This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Congress Materials

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.
Poster
Hang Li, Hao Cheng, Qianjin Lu, Wei Lai, Xiaohua Tao, Gerardo A. Encinas, Shefali Vyas, Bo Wang, Xin Luo, Shiqi Li December 11, 2022 RAD Dec 2022 Atopic Dermatitis

Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: a post hoc sub-analysis of the JADE REGIMEN phase 3 trial

View Presentation
Oral Presentation
Jonathan I. Silverberg, Sonja Ständer, Jacob P. Thyssen, Brian S. Kim, Carla Castro, Anthony Bewley, Laurent Misery, Andrew G. Bushmakin, Joseph C. Cappelleri, Erman Guler, Justine Alderfer, Melisa Watkins, Gary Chan, Daniela E. Myers December 11, 2022 RAD Dec 2022 Atopic Dermatitis

Examining the Relationships Among Abrocitinib Treatment, Itch, Skin Pain, and Dermatology-specific Quality of Life in Patients With Atopic Dermatitis: A Mediation Modelling Analysis

View Presentation
Poster
Jonathan I. Silverberg, Sonja Ständer, Jacob P. Thyssen, Brian S. Kim, Carla Castro, Anthony Bewley, Laurent Misery, Andrew G. Bushmakin, Joseph C. Cappelleri, Erman Guler, Justine Alderfer, Melisa Watkins, Gary Chan, Daniela E. Myers December 11, 2022 RAD Dec 2022 Atopic Dermatitis

Examining the Relationships Among Abrocitinib Treatment, Itch, Skin Pain, and Work and Activity Impairments in Patients With Atopic Dermatitis: A Mediation Modelling Analysis

View Presentation
Poster
Richard Gower, JinHua Xu, Maryam S. Alam, John C. Su, Daniela E. Myers, Paul Sanders, Bonnie Vlahos, Chuanbo Zang, Jar Lan, John Werth December 11, 2022 RAD Dec 2022 Atopic Dermatitis

Once-Daily Crisaborole as a Long-Term Maintenance Treatment in Participants With Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Trial

View Presentation
Poster
Eric L. Simpson, Jonathan I. Silverberg, Audrey Nosbaum, Kevin Winthrop, Emma Guttman-Yassky, Karin M. Hoffmeister, Alexander Egeberg, Hernan Valdez, Haiyun Fan, Saleem A. Farooqui, Gary Chan, Justine Alderfer, William Romero, Susan Johnson PO not an author: Sylvia Li December 11, 2022 RAD Dec 2022 Atopic Dermatitis

Safety of Abrocitinib in 3582 Patients With Moderate-to-Severe Atopic Dermatitis With Over 900 Patients Exposed for Almost 2 Years

View Presentation
Oral Presentation
Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen, Andrew E. Pink, Stephan Weidinger, Gary Chan, Irina Lazariciu, Claire Clibborn, Erman Guler December 11, 2022 RAD Dec 2022 Atopic Dermatitis

Switching from Dupilumab to Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis: An Analysis of Responders and Nonresponders to Dupilumab

View Presentation